DP
Dr. Rahul Pawara
R. C. Patel Institute of Pharmacy, R. C. Patel Institute of Pharmaceutical Education and Research Shirpur, R. C. Patel Institute of Pharmaceutical Education and Research
Employment
-
R. C. Patel Institute of Pharmacy2016 - Present
Education
-
R. C. Patel Institute of Pharmaceutical Education and Research Shirpur Ph. D.2019 - 2023
-
R. C. Patel Institute of Pharmaceutical Education and Research M. Pharmacy2012 - 2014
-
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research B. Pharmacy2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Structural Exploration of Pyrazine‐1,2,3‐Triazole Hybrids as Selective Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease Save
- A facile and efficient one-pot procedure for the synthesis of 2-amino-4,8-dihydropyrano[3,2-b]pyran-3-carbonitriles in PEG-400 and glycerol Save
- Triazolopyridine, a leitmotif of synthetic methods and pharmacological attributes: An extensive review Save
- Informatics and databases for phytochemical drug discovery Save
- In silico toxicity investigation of Methaqualone’s conjunctival, retinal, and gastrointestinal hemorrhage by molecular modelling approach Save
- Synthesis, Molecular Modeling Study, and Quantum-Chemical-Based Investigations of Isoindoline-1,3-diones as Antimycobacterial Agents Save
- Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC) Save
- Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach Save
- Synthesis, molecular modelling study of the methaqualone analogues as anti-convulsant agent with improved cognition activity and minimized neurotoxicity Save
- Fourth-Generation Allosteric EGFR Tyrosine Kinase Inhibitors to Combat the Drug Resistance Associated with Non-small Cell Lung Cancer (NSCLC) Save